The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.20
Bid: 169.60
Ask: 170.20
Change: 6.20 (3.78%)
Spread: 0.60 (0.354%)
Open: 162.00
High: 170.60
Low: 162.00
Prev. Close: 164.00
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

25 Mar 2021 14:41

RNS Number : 5402T
Forterra plc
25 March 2021
 

25 March 2021

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the vesting on 1 May 2020 of share options granted to management under the 2017 Performance Share Plan (PSP), the Company was notified on the 24 March 2021 that on the 23 March 2021 the following exercise and sale transactions took place:

George Stewart, Operations Director exercised options granted under the PSP as laid out below selling sufficient shares to cover the appropriate tax and national insurance liabilities.

Name

Status

No. of shares exercised

Sale Date

Number of shares sold

Price

Number of shares retained

Beneficial interest

% of ISC

 

George Stewart

PDMR

24,677

23/03/21

11,704

£2.71

12,973

52,593

< 1%

The 2017 PSP awards were granted with half of the awards subject to an EPS performance condition and the other half of the awards subject to a TSR performance condition. The EPS performance condition vested at 43.57% of the maximum and the TSR performance condition vested at 90.01%. The Remuneration Committee determined that, in accordance with the rules of the scheme, participants would receive dividend equivalent shares at the rate of 1.102917 additional share for every vesting share. The Remuneration Committee also agreed to waive the 1p per option cost upon exercise.

The shares to be retained by management are to be transferred to management by the Employee Benefit Trust.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Ashley Thompson (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

George Stewart

2.

Reason for the notification

a)

Position/status

PDMR (Operations Director)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

213800O5DD6ATBVJAD23

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP scheme on 25 April 2017 and vesting on 1 May 2020

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.71

 

 

£Nil

24,677 options vesting

 

11,704 shares sold to settle tax and NI

 

12,973 shares acquired

 

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.71

11,704

£31,717.84

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPURWWUPGGCA
Date   Source Headline
2nd Mar 20224:32 pmRNSEmployee Benefit Trust Share Purchase
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:00 pmRNSTotal Voting Rights
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20228:26 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:00 amRNSTransaction in Own Shares
10th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:30 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSShare buyback programme
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20226:05 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20227:30 amRNSTransaction in Own Shares
31st Jan 20225:15 pmRNSTotal Voting Rights
31st Jan 20227:30 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:36 amRNSProgressive publishes new research
26th Jan 20227:00 amRNSPre-close trading update
6th Jan 20224:02 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20215:31 pmRNSEmployee Benefit Trust Share Purchase
25th Nov 20218:01 amRNSProgressive publishes new research
25th Nov 20217:00 amRNSTrading Update
2nd Nov 20215:12 pmRNSEmployee Benefit Trust Share Purchase
1st Nov 20211:51 pmRNSDirector Declaration
13th Oct 20217:06 amRNSHolding(s) in Company
7th Oct 20215:12 pmRNSDirector/PDMR Shareholding
6th Oct 20217:51 amRNSHolding(s) in Company
5th Oct 20215:49 pmRNSEmployee Benefit Trust Share Purchase
28th Sep 20219:28 amRNSEmployee Benefit Trust Share Purchase
23rd Sep 20218:33 amRNSHolding(s) in Company
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.